p53 immunostaining suggests that uterine carcinosarcomas are monoclonal. | Histopathology;24(3): 211-4, 1994 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

p53 immunostaining suggests that uterine carcinosarcomas are monoclonal.

Mayall, F; Rutty, K; Campbell, F; Goddard, H.

Affiliation

Mayall F; Lancaster Moor Hospital, UK.

Histopathology ; 24(3): 211-4, 1994 Mar.

Article in En | MEDLINE | ID: mdl-8200622

Subject(s)

Carcinosarcoma/chemistry; Mixed Tumor, Mullerian/chemistry; Tumor Suppressor Protein p53/analysis; Uterine Neoplasms/chemistry; Carcinosarcoma/genetics; Female; Genes, p53; Humans; Immunohistochemistry; Mixed Tumor, Mullerian/genetics; Uterine Neoplasms/genetics

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Carcinosarcoma / Tumor Suppressor Protein p53 / Mixed Tumor, Mullerian Limits: Female / Humans Language: En Journal: Histopathology Year: 1994 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Carcinosarcoma / Tumor Suppressor Protein p53 / Mixed Tumor, Mullerian Limits: Female / Humans Language: En Journal: Histopathology Year: 1994 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom